“EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA: Empiric Glycopeptide Use in Neutropenic Fever”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 14, no. 1, Apr. 2022, p. e2022039, https://doi.org/10.4084/MJHID.2022.039.